Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Ohio State experts to review FDA regulation of prescription opioids

November 21, 2022

Ohio State experts to review FDA regulation of prescription opioids

TDAI Core Faculty member Macarius Donneyong, assistant professor of outcomes and translational sciences in the College of Pharmacy and College of Public Health, is part of a team of Ohio State University experts that has been awarded a contract through Brillient Corporation to complete an independent review of the Food and Drug Administration's regulatory actions and decisions on currently approved opioid medications.  Read more.

News Filters:

TDAI Core Faculty
TDAI News
COP - Computational Health and Life Sciences
Ohio State University